Uroxatral (Alfuzosin Hydrochloride) - Summary

UROXATRAL SUMMARY

UROXATRAL®
(alfuzosin HCl extended-release tablets)

Each UROXATRAL (alfuzosin HCl extended-release tablets) tablet contains 10 mg alfuzosin hydrochloride as the active ingredient. Alfuzosin hydrochloride is a white to off-white crystalline powder that melts at approximately 240°C. It is freely soluble in water, sparingly soluble in alcohol, and practically insoluble in dichloromethane.

UROXATRAL (alfuzosin HCl extended-release tablets) is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia.

UROXATRAL is not indicated for the treatment of hypertension.

UROXATRAL NEWS HIGHLIGHTS

Media Articles Related to Uroxatral (Alfuzosin)

Medical Management Of Benign Prostatic Hyperplasia (BPH)/Lower Urinary Tract Symptoms (LUTS)
Source: Prostate / Prostate Cancer News From Medical News Today [2008.08.11]

Benign Prostatic Hyperplasia
Source: MedicineNet Aches, Pain, Fever Specialty [2008.06.23]

Medical and Surgical Treatment of Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia: State of the Art
Source: Medscape Pharmacotherapy Headlines [2004.06.11]

more>>

Published Studies Related to Uroxatral (Alfuzosin)

Alfuzosin stone expulsion therapy for distal ureteral calculi: a double-blind, placebo controlled study. [2008.06]

Rapid onset of action with alfuzosin 10 mg once daily in men with benign prostatic hyperplasia: a randomized, placebo-controlled trial. [2007.01.09]

Rapid onset of action with alfuzosin 10 mg once daily in men with benign prostatic hyperplasia: a randomized, placebo-controlled trial. [2007]

Alfuzosin (10 mg) does not affect blood pressure in young healthy men. [2006.12]

Effects of acute treatment with tamsulosin versus alfuzosin on ejaculatory function in normal volunteers. [2006.10]

more>>

Clinical Trials Related to Uroxatral (Alfuzosin)

The Long Term Effects of Alfuzosin(Xatral XL) in LUTS/BPH Patients: Evaluation of Voiding and Storage Function [Active, not recruiting]

Multicenter Prospective Study on the Changes of Sexual Function Following Treatment With Alfuzosin (Xatral XL®) in Patients With Benign Prostate Hypertrophy [Completed]

Alfuzosin XL Lower Urinary Tract Symptoms Efficacy and Sexuality Study [Completed]

Once Daily Given Alfuzosin in the Treatment of BPH [Completed]

Trial to Compare Alfuzosin Versus Placebo in the Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome [Completed]

more>>